Pathogenetic treatment with strontium ranelate in women with postmenopausal osteoporosis
The possibility of recovering the functional status is now considered as an integral part of the development of new treatment strategies for chronic diseases, including osteoporosis (OP). The possibility to optimize the treatment of OP, by exerting a more physiological effect on bone and simultaneou...
Main Author: | Olga Borisovna Yershova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2010-12-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/323 |
Similar Items
-
Strontium ranelate in the treatment of postmenopausal osteoporosis: results of administration in clinical practice
by: N V Toroptsova, et al.
Published: (2008-06-01) -
Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation
by: Kurtuluş Kaya, et al.
Published: (2009-12-01) -
STRONTIUM RANELATE IS THE DRUG OF CHOICE IN THE TREATMENT OF OSTEOPOROSIS
by: Nataliya Vladimirovna Toroptsova
Published: (2010-09-01) -
POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION
by: N. J. Hozjainova, et al.
Published: (2016-01-01) -
Comparison of the Effects of Strontium Ranelate and Raloxiphene on Bone Mineral Density in Postmenopausal Osteoporosis - Original Investigation
by: Figen Yılmaz, et al.
Published: (2009-04-01)